Focus Partners Advisor Solutions’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Focus Partners Advisor Solutions's ABBV Position: Q2 2026 in Review
Focus Partners Advisor Solutions increased its AbbVie (ABBV) stake by 24% in Q2 2026, buying an estimated $1.63M and bringing the position to 39,485 shares worth $9.94M. The position accounts for 0.08% of the portfolio, ranked #117.
Focus Partners Advisor Solutions first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. The position peaked at $11.5M in Q4 2025. 4,217 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Focus Partners Advisor Solutions held 39,485 shares of AbbVie worth $9.94M as of Q2 2026.
- Focus Partners Advisor Solutions bought 7,576 AbbVie shares in Q2 2026, an estimated $1.63M.
- AbbVie made up 0.08% of Focus Partners Advisor Solutions's portfolio in Q2 2026, its #117 holding.
- Focus Partners Advisor Solutions first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
- Focus Partners Advisor Solutions's AbbVie position peaked at $11.5M in Q4 2025.
- 4,217 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Focus Partners Advisor Solutions's 13F filing for Q2 2026, filed 6 Aug 2026.